SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense community debate over its long-term utility and institutional adoption, with sentiment split between those viewing the current price as a key accumulation opportunity and others concerned by stagnant performance. Discussions are heavily focused on the uncertainty surrounding the Clarity Act and how regulatory progressor lack thereofis impacting the token's ability to maintain structural support.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing heightened volatility following its latest earnings report, where strong revenue growth and upbeat guidance were overshadowed by investor concerns over premium valuations and aggressive expansion risks. The community remains deeply divided, with bulls pointing to the strategic acquisition of former Salad and Go locations and robust consumer demand as key drivers for long-term growth, while skeptics warn that insider selling and elevated P/E multiples could keep the stock pressured in the near term.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The IWM is trending as institutional investors aggressively increase put option volume, signaling a tactical hedge against potential downside volatility despite recent price resilience. Market participants remain focused on navigating this uncertainty by balancing index-level risk with shifting sector leadership across the broader equities landscape.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is seeing heightened community engagement as traders speculate on a potential breakout driven by a weakening U.S. dollar and ongoing debates regarding silver's role as a macro hedge against fiscal uncertainty. Investors are closely monitoring key support levels and silver's industrial demand profile, with many actively debating whether current price consolidation is a healthy base for a long-term rally or a precursor to further downside.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins (PENGU) is seeing high community engagement as traders speculate on a potential breakout, driven by its branding and active IP development. While some participants are actively accumulating positions in anticipation of a broader meme coin rally, others remain skeptical, pointing to historical volatility and recent price consolidation.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened investor attention driven by strong institutional accumulation from major players like BlackRock and anticipation surrounding upcoming quarterly earnings. The community is actively discussing the company's competitive positioning, organic revenue growth from strategic government contracts, and its potential as a long-term leader in the quantum sector.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing strong momentum as multiple firms raise price targets following a robust quarterly performance driven by the expansion of its Vector AI ad platform. Investors are closely watching how the company executes its turnaround and captures market share, with active community discussion focused on its long-term potential as a key player in the AI-driven ad tech space.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF remains a focal point as investors grapple with heightened volatility and institutional selling pressure surrounding Bitcoin's recent price retracement. Market participants are actively debating the long-term impact of large-scale BTC liquidations and shifting macroeconomic catalysts, while monitoring how new regulatory developments might influence future momentum.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense community speculation centered on the potential for a near-term buyout, with investors closely watching activist CEO Kevin Tang's strategic silence and significant personal stake as indicators of a major upcoming transaction. While the company maintains a strong cash position and profitable revenue growth, sentiment remains polarized between those anticipating a high-premium acquisition fueled by its autoimmune franchise and those frustrated by a lack of transparency, patent litigation uncertainty, and recent volatility.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is trending as shares face significant downward pressure following an earnings update that featured disappointing guidance and the withdrawal of annual financial targets. The community is actively debating the stock's future, with many users expressing skepticism over the platform's monetization strategy and child safety concerns while others view the sell-off as a potential entry point for long-term growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year?

Here is how Artiva Biotherapeutics, Inc. (ARTV) and Climb Bio, Inc. (CLYM) have performed compared to their sector so far this year.

Climb Bio (NASDAQ:CLYM) Reaches New 52-Week High Following Analyst Upgrade

Climb Bio (NASDAQ:CLYM) Reaches New 52-Week High Following Analyst Upgrade...

Climb Bio (NASDAQ:CLYM) Stock Price Expected to Rise, BTIG Research Analyst Says

BTIG Research boosted their price objective on shares of Climb Bio from $8.00 to $19.00 and gave the company a 'buy' rating in a report on Wednesday...

Climb Bio (NASDAQ:CLYM) Trading 10.8% Higher - What's Next?

Climb Bio (NASDAQ:CLYM) Trading 10.8% Higher - What's Next...

Climb Bio Spotlights Budoprutug CD19 Strategy, Sets Up 2026 Data Readouts in pMN, ITP and SLE

Climb Bio (NASDAQ:CLYM) used an investor R&D spotlight event to outline its strategy around CD19-targeted B-cell depletion and to provide updates on development plans and timelines for its lead...

Climb Bio, Inc. $CLYM Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. reduced its stake in Climb Bio, Inc. (NASDAQ:CLYM - Free Report) by 89.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...

Climb Bio, Inc. (NASDAQ:CLYM) Receives Average Recommendation of "Buy" from Brokerages

Shares of Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) have been assigned an average recommendation of "Buy" from the twelve analysts that are currently covering the stock, Marketbeat reports. One...

Oppenheimer Raises Climb Bio (NASDAQ:CLYM) Price Target to $18.00

Oppenheimer upped their price target on shares of Climb Bio from $10.00 to $18.00 and gave the stock an "outperform" rating in a research report on Tuesday...

Climb Bio (NASDAQ:CLYM) Upgraded to "Strong-Buy" at Mizuho

Mizuho raised Climb Bio to a "strong-buy" rating in a research report on Wednesday...

Climb Bio's (CLYM) "Buy" Rating Reaffirmed at BTIG Research

BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Climb Bio in a research report on Wednesday...

Climb Bio, Inc. operates as a clinical-stage biotechnology company. The firm develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.

Climb Bio Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CLYMClimb Bio Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest CLYM News